NABL announces joint technical training programme with MANTRA on medical textiles testing: Shardul Nautiyal, Mumbai Wednesday, November 13, 2024, 08:00 Hrs [IST] The National Accr ...
Paratek Pharma announces positive top-line data from phase 2b study of oral omadacycline in NTM abscessus pulmonary disease: Boston Monday, November 11, 2024, 18:00 Hrs [IST] Para ...
Nuzyra also showed improvement in microbiological endpoints, with 56.4% of treatment group patients having negative sputum cultures for mycobacterium abscessus compared to 29.2% of the placebo group.